Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A00012 | Pages: 244 | Charts: 65 | Tables: 113 |
The global digital pathology market size was valued at $735.75 million in 2020, and is expected to reach $1791.30 million by 2030, registering a CAGR of 9.3% from 2021 to 2030. Digital pathology is a computer-enabled, image-based information platform that helps for the management of information generated from digital slides. Growth of the global digital pathology market is majorly driven by increase in prevalence of cancer; rise in the demand for accurate diagnostics, and development of new digital pathology system by large number of key players. According to report published by Medscape, chronic diseases can be associated to the higher mortality rate. The fundamental cause for the development of advanced diagnostic solutions is the rise prevalence of cardiovascular disorders.. Thus, as the prevalence of chronic and cardiovascular diseases rises, the need for digital pathology systems increases driving the growth of the digital pathology market.
Digital pathology technology can aid a research pipeline in two ways. The first one is that the specified file storage and viewing applications may be used to arrange macroscopic images, tissue microarrays, and entire slide images. The second application of digital pathology in research is the development and implementation of image analysis techniques.
Rise in geriatric population and rapid technological advancements in digital pathology systems are the factors that fuel the growth of the digital pathology market. According to the National Cancer Statistics in 2020, around 1,806,590 new cases of cancer in the U.S. Therefore, the growing number of cancer cases can be attributed to the rapid increase in geriatric population which is more prone to cardiac disorders. This is anticipated to boost the growth of the market. In addition, in February 2019, Neuberg Diagnostics and OptraSCAN Inc., announced the launch of Global TELEPath Network for the pathologist community in UAE, India and South Africa under new joint venture namely Neuberg DIGIPATH. Therefore, development of new technologies in digital pathology system has led to increase the growth of the market.
The COVID-19 outbreak is anticipated to have a positive impact to fuel the growth of the global digital pathology market. The Center for Devices and Radiological Health of the U.S. FDA released an enforcement policy for remote digital pathology devices, which are intended for pathologists, clinical laboratories, and drug administration staff. Thus, rise in cases of chronic diseases has increased the usage of digital pathology systems for diagnosis, which is anticipated to drive the digital pathology market during the forecast period.
Thus, new innovations by key players and rise in number of product approvals propel the growth of the market. However, high cost associated with digital pathology systems is expected to hinder the market growth during the forecast period.
The digital pathology market is segmented into type, application, end user, and region. On the basis of type, the market is categorized into scanners, software, and storage & communication systems. On the basis of application, it is divided into teleconsultation, disease diagnosis, drug discovery, and training & education. On the basis of end user, it is categorized into educational, clinical, and pharma & biotech companies. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
On the basis of type, the scanners segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in R&D activities in the pharmaceutical & medical device industry, rise in demand for diagnosis of diseases, and surge in adoption of digital pathology systems. However, the disease software segment is expected to witness considerable growth during the forecast period, owing to increase in number of cancer cases and growth in number of key players for development of digital pathology systems in the medical device industry.
[TYPEGRAPH]
On the basis of application, the disease diagnosis segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to increase in number of chronic diseases, rise in the number of cardiac disorders, and increase in demand for digital pathology systems for disease diagnosis. However, the drug discovery is expected to witness considerable growth during the forecast period due to increase in number of cancer cases, rise in use of digital pathology systems, and development of new digital pathology systems in the clinical laboratories.
On the basis of end user, the pharma & biotech companies segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to large number key players offering digital pathology systems, increase in demand for educational practices, development of novel & innovative pathology systems, and advancement in R&D activities. However, the clinical segment is expected to witness considerable growth during the forecast period, owing to increase in cardiovascular diseases, and surge in usage of digital pathology system to determine the efficacy of treatment.
[APPLICATIONGRAPH]
North America dominated the digital pathology market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in number of various types of cancer cases, presence of key players, development of the healthcare sector, and presence of new innovative digital pathology systems in the region. However, Asia-Pacific is expected to register the highest CAGR of 10.6 % from 2021 to 2030, owing to increase in prevalence of chronic diseases, and development of healthcare infrastructure.
[REGIONGRAPH]
The major companies profiled in the digital pathology market report include 3DHISTECH LTD, Danaher Corporation, Glencoe Software Inc., HAMAMTSU Photonics K.K, Indica Labs Inc., Koninklijke Philips N.V, Nikon Corporation, Perkinelmer Inc., Roche, and VisoPharma A/S.
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top Investment Pockets
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Surge in use of digital pathology in disease diagnosis
3.4.1.2.Increase in prevalence of chronic diseases
3.4.1.3.Increase in adoption of artificial intelligence based digital tools
3.4.2.Restraint
3.4.2.1.High cost of digital pathology solution
3.4.3.Opportunity
3.4.3.1.Introduction of affordable scanners for private pathology practices
3.4.4.Impact analysis
3.5.COVID 19 Impact Analysis on the digital pathology market
CHAPTER 4:DIGITAL PATHOLOGY MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Scanners
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market size and forecast, by country
4.3.Software
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market size and forecast, by country
4.4.Storage & communication system
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market size and forecast, by country
CHAPTER 5:DIGITAL PATHOLOGY MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Teleconsultation
5.2.1.Market size and forecast, by region
5.2.2.Market size and forecast, by country
5.3.Disease diagnosis
5.3.1.Market size and forecast, by region
5.3.2.Market size and forecast, by country
5.4.Drug discovery
5.4.1.Market size and forecast, by region
5.4.2.Market size and forecast, by country
5.5.Training & education
5.5.1.Market size and forecast, by region
5.5.2.Market size and forecast, by country
CHAPTER 6:DIGITAL PATHOLOGY MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Educational
6.2.1.Market size and forecast, by region
6.2.2.Market size and forecast, by country
6.3.Clinical
6.3.1.Market size and forecast, by region
6.3.2.Market size and forecast, by country
6.4.Pharma & Biotech Companies
6.4.1.Market size and forecast, by region
6.4.2.Market size and forecast, by country
CHAPTER 7:DIGITAL PATHOLOGY MARKET, BY REGION
7.1.Market overview
7.1.1.Market size and forecast, by region
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by product
7.2.3.Market size and forecast, by application
7.2.4.Market size and forecast, by end user
7.2.5.North America Market size and forecast, by country
7.2.5.1.U.S.
7.2.5.1.1.Market size and forecast, by product
7.2.5.1.2.Market size and forecast, by application
7.2.5.1.3.Market size and forecast, by end user
7.2.5.2.Canada
7.2.5.2.1.Market size and forecast, by product
7.2.5.2.2.Market size and forecast, by application
7.2.5.2.3.Market size and forecast, by end user
7.2.5.3.Mexico
7.2.5.3.1.Market size and forecast, by product
7.2.5.3.2.Market size and forecast, by application
7.2.5.3.3.Market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by product
7.3.3.Market size and forecast, by application
7.3.4.Market size and forecast, by end user
7.3.5.Europe Market size and forecast, by country
7.3.5.1.Germany
7.3.5.1.1.Market size and forecast, by product
7.3.5.1.2.Market size and forecast, by application
7.3.5.1.3.Market size and forecast, by end user
7.3.5.2.France
7.3.5.2.1.Market size and forecast, by product
7.3.5.2.2.Market size and forecast, by application
7.3.5.2.3.Market size and forecast, by end user
7.3.5.3.UK
7.3.5.3.1.Market size and forecast, by product
7.3.5.3.2.Market size and forecast, by application
7.3.5.3.3.Market size and forecast, by end user
7.3.5.4.Italy
7.3.5.4.1.Market size and forecast, by product
7.3.5.4.2.Market size and forecast, by application
7.3.5.4.3.Market size and forecast, by end user
7.3.5.5.Spain
7.3.5.5.1.Market size and forecast, by product
7.3.5.5.2.Market size and forecast, by application
7.3.5.5.3.Market size and forecast, by end user
7.3.5.6.Rest of Europe
7.3.5.6.1.Market size and forecast, by product
7.3.5.6.2.Market size and forecast, by application
7.3.5.6.3.Market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by product
7.4.3.Market size and forecast, by application
7.4.4.Market size and forecast, by end user
7.4.5.Asia-Pacific Market size and forecast, by country
7.4.5.1.Japan
7.4.5.1.1.Market size and forecast, by product
7.4.5.1.2.Market size and forecast, by application
7.4.5.1.3.Market size and forecast, by end user
7.4.5.2.China
7.4.5.2.1.Market size and forecast, by product
7.4.5.2.2.Market size and forecast, by application
7.4.5.2.3.Market size and forecast, by end user
7.4.5.3.Australia
7.4.5.3.1.Market size and forecast, by product
7.4.5.3.2.Market size and forecast, by application
7.4.5.3.3.Market size and forecast, by end user
7.4.5.4.India
7.4.5.4.1.Market size and forecast, by product
7.4.5.4.2.Market size and forecast, by application
7.4.5.4.3.Market size and forecast, by end user
7.4.5.5.South Korea
7.4.5.5.1.Market size and forecast, by product
7.4.5.5.2.Market size and forecast, by application
7.4.5.5.3.Market size and forecast, by end user
7.4.5.6.Rest of Asia-Pacific
7.4.5.6.1.Market size and forecast, by product
7.4.5.6.2.Market size and forecast, by application
7.4.5.6.3.Market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by product
7.5.3.Market size and forecast, by application
7.5.4.Market size and forecast, by end user
7.5.5.LAMEA Market size and forecast, by country
7.5.5.1.Brazil
7.5.5.1.1.Market size and forecast, by product
7.5.5.1.2.Market size and forecast, by application
7.5.5.1.3.Market size and forecast, by end user
7.5.5.2.Saudi Arabia
7.5.5.2.1.Market size and forecast, by product
7.5.5.2.2.Market size and forecast, by application
7.5.5.2.3.Market size and forecast, by end user
7.5.5.3.South Africa
7.5.5.3.1.Market size and forecast, by product
7.5.5.3.2.Market size and forecast, by application
7.5.5.3.3.Market size and forecast, by end user
7.5.5.4.Rest of LAMEA
7.5.5.4.1.Market size and forecast, by product
7.5.5.4.2.Market size and forecast, by application
7.5.5.4.3.Market size and forecast, by end user
CHAPTER 8:COMPETITIVE LANDSCAPE
8.1.Introduction
8.2.Top winning strategies
8.2.1.Top winning strategies, by year, 2018-2023*
8.2.2.Top winning strategies, by development, 2018-2023*
8.2.3.Top winning strategies, by company, 2020-2023*
8.3.Product mapping of top 12 player
8.4.Competitive dashboard
8.5.Competitive heatmap
8.6.Top player positioning
CHAPTER 9:COMPANY PROFILES
9.1.3DHISTECH LTD.
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Key strategic moves and developments
9.2.DANAHER CORPORATION (LEICA MICROSYSTEM)
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments
9.3.GLENCOE SOFTWARE, INC.
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.4.HAMAMATSU PHOTONICS K.K.
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments
9.5.INDICA LABS INC.
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Key strategic moves and developments
9.6.KONINKLIJKE PHILIPS N.V.
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments
9.7.NIKON CORPORATION
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments
9.8.PERKINELMER INC.
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.9.F. HOFFMANN LA-ROCHE
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments
9.10.VISIOPHARM A/S
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Key strategic moves and developments
9.11.PAIGE AI, INC.
9.11.1.Company overview
9.11.2.Company snapshot
9.11.3.Operating business segments
9.11.4.Product portfolio
9.11.5.Key strategic moves and developments
9.12.PATHAI, INC.
9.12.1.Company overview
9.12.2.Company snapshot
9.12.3.Operating business segments
9.12.4.Product portfolio
9.12.5.Key strategic moves and developments
LIST OF TABLES
TABLE 01.DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 02.DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY REGION, 2020–2030 ($MILLION)
TABLE 03.DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY REGION, 2020–2030 ($MILLION)
TABLE 04.DIGITAL PATHOLOGY MARKET FOR STORAGE AND COMMUNICATION SYSTEMS, BY REGION, 2020–2030 ($MILLION)
TABLE 05.DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 06.DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY REGION, 2020–2030 ($MILLION)
TABLE 07.DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2020–2030 ($MILLION)
TABLE 08.DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY REGION, 2020–2030 ($MILLION)
TABLE 09.DIGITAL PATHOLOGY MARKET FOR TRAINING AND EDUCATION, BY REGION, 2020–2030 ($MILLION)
TABLE 10.DIGITAL PATHOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 11.DIGITAL PATHOLOGY MARKET FOR EDUCATIONAL, BY REGION, 2020–2030 ($MILLION)
TABLE 12.DIGITAL PATHOLOGY MARKET FOR CLINICAL, BY REGION, 2020–2030 ($MILLION)
TABLE 13.DIGITAL PATHOLOGY MARKET FOR PHARMA AND BIOTECH COMPANIES, BY REGION, 2020–2030 ($MILLION)
TABLE 14.DIGITAL PATHOLOGY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 15.NORTH AMERICA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 16.NORTH AMERICA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 17.NORTH AMERICA DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 19.U.S. DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 20.U.S. DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 21.U.S. DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 22.CANADA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 23.CANADA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 24.CANADA DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 25.MEXICO DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 26.MEXICO DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 27.MEXICO DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 28.EUROPE DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 29.EUROPE DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 30.EUROPE DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31.EUROPE DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 32.GERMANY DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 33.GERMANY DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 34.GERMANY DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35.FRANCE DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 36.FRANCE DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 37.FRANCE DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38.UK DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 39.UK DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 40.UK DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 41.ITALY DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 42.ITALY DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 43.ITALY DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44.SPAIN DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 45.SPAIN DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 46.SPAIN DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 47.REST OF EUROPE DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 48.REST OF EUROPE DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 49.REST OF EUROPE DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 50.ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 51.ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 52.ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 53.ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 54.JAPAN DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 55.JAPAN DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 56.JAPAN DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57.CHINA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 58.CHINA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 59.CHINA DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 60.AUSTRALIA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 61.AUSTRALIA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 62.AUSTRALIA DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 63.INDIA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 64.INDIA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 65.INDIA DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 66.SOUTH KOREA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 67.SOUTH KOREA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 68.SOUTH KOREA DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 72.LAMEA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 73.LAMEA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 74.LAMEA DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 75.LAMEA DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 76.BRAZIL DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 77.BRAZIL DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 78.BRAZIL DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 79.SAUDI ARABIA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 80.SAUDI ARABIA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 81.SAUDI ARABIA DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 82.SOUTH AFRICA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 83.SOUTH AFRICA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 84.SOUTH AFRICA DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 85.REST OF LAMEA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 86.REST OF LAMEA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 87.REST OF LAMEA DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 88.3DHISTECH: COMPANY SNAPSHOT
TABLE 89.3DHISTECH: PRODUCT PORTFOLIO
TABLE 90.DANAHER: COMPANY SNAPSHOT
TABLE 91.DANAHER: OPERATING SEGMENTS
TABLE 92.DANAHER: PRODUCT PORTFOLIO
TABLE 93.GLENCOE SOFTWARE: COMPANY SNAPSHOT
TABLE 94.GLENCOE SOFTWARE: PRODUCT PORTFOLIO
TABLE 95.HAMAMATSU: COMPANY SNAPSHOT
TABLE 96.HAMAMATSU: OPERATING SEGMENTS
TABLE 97.HAMAMATSU: PRODUCT PORTFOLIO
TABLE 98.INDICA LABS: COMPANY SNAPSHOT
TABLE 99.INDICA LABS: PRODUCT PORTFOLIO
TABLE 100.PHILIPS: COMPANY SNAPSHOT
TABLE 101.PHILIPS: OPERATING SEGMENTS
TABLE 102.PHILIPS: PRODUCT PORTFOLIO
TABLE 103.NIKON: COMPANY SNAPSHOT
TABLE 104.NIKON: OPERATING SEGMENTS
TABLE 105.NIKON: PRODUCT PORTFOLIO
TABLE 106.PERKINELMER: COMPANY SNAPSHOT
TABLE 107.PERKINELMER: OPERATING SEGMENTS
TABLE 108.PERKINELMER: PRODUCT PORTFOLIO
TABLE 109.ROCHE: COMPANY SNAPSHOT
TABLE 110.ROCHE: OPERATING SEGMENTS
TABLE 111.ROCHE: PRODUCT PORTFOLIO
TABLE 112.VISIOPHARM: COMPANY SNAPSHOT
TABLE 113.VISIOPHARM: PRODUCT PORTFOLIO
TABLE 114.PAIGE: COMPANY SNAPSHOT
TABLE 115.PAIGE: PRODUCT PORTFOLIO
TABLE 116.PATHAI: COMPANY SNAPSHOT
TABLE 117.PATHAI: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.EXECUTIVE SUMMARY
FIGURE 02.DIGITAL PATHOLOGY MARKET SEGMENTATION
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
FIGURE 06.MODERATE THREAT OF SUBSTITUTES
FIGURE 07.MODERATE THREAT OF NEW ENTRANTS
FIGURE 08.MODERATE INTENSITY OF RIVALRY
FIGURE 09.IMPACT ANALYSIS
FIGURE 10.DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020-2030 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY COUNTRY, 2020 AND 2030 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY COUNTRY, 2020 AND 2030 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR STORAGE AND COMMUNICATION SYSTEMS, BY COUNTRY, 2020 AND 2030 (%)
FIGURE 14.DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020-2030 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY COUNTRY, 2020 AND 2030 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2020 AND 2030 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2020 AND 2030 (%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR TRAINING AND EDUCATION, BY COUNTRY, 2020 AND 2030 (%)
FIGURE 19.DIGITAL PATHOLOGY MARKET, BY END USER, 2020-2030 (%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR EDUCATIONAL, BY COUNTRY, 2020 AND 2030 (%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR CLINICAL, BY COUNTRY, 2020 AND 2030 (%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR PHARMA AND BIOTECH COMPANIES, BY COUNTRY, 2020 AND 2030 (%)
FIGURE 23.DIGITAL PATHOLOGY MARKET BY REGION, 2020-2030(%)
FIGURE 24.U.S. DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 25.CANADA DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 26.MEXICO DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 27.GERMANY DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 28.FRANCE DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 29.UK DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 30.ITALY DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 31.SPAIN DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 32.REST OF EUROPE DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 33.JAPAN DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 34.CHINA DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 35.AUSTRALIA DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 36.INDIA DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 37.SOUTH KOREA DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 38.REST OF ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 39.BRAZIL DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 40.SAUDI ARABIA DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 41.SOUTH AFRICA DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 42.REST OF LAMEA DIGITAL PATHOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 43.TOP WINNING STRATEGIES, BY YEAR, 2018-2023*
FIGURE 44.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2023*
FIGURE 45.TOP WINNING STRATEGIES, BY COMPANY, 2020-2023*
FIGURE 46.PRODUCT MAPPING OF TOP 12 PLAYERS
FIGURE 47.COMPETITIVE DASHBOARD
FIGURE 48.COMPETITIVE HEATMAP: DIGITAL PATHOLOGY MARKET
FIGURE 49.TOP PLAYER POSITIONING, 2022
FIGURE 50.DANAHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 51.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 52.DANAHER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 53.HAMAMATSU: NET SALES, 2018–2020 ($MILLION)
FIGURE 54.PHILIPS: NET SALES, 2018–2020 ($MILLION)
FIGURE 55.PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 56.PHILIPS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 57.NIKON: NET SALES, 2018–2020 ($MILLION)
FIGURE 58.NIKON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 59.NIKON: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 60.PERKINELMER: NET SALES, 2018–2020 ($MILLION)
FIGURE 61.PERKINELMER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 62.PERKINELMER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 63.ROCHE: NET SALES, 2018–2020 ($MILLION)
FIGURE 64.ROCHE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 65.ROCHE: REVENUE SHARE BY REGION, 2020 (%)